Stoke Therapeutics (STOK) Net Shares Issued and Repurchased (2018 - 2026)
Powered by 
Analysis
Stoke Therapeutics (STOK) Net Shares Issued and Repurchased (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | - |
| 10 | Stoke Therapeutics | 1.96 Bn | 1.66 Bn | - | 529,855.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 529,855.00 |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 809,300.00 |
| Jun 30, 2025 | 407,482.00 |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 729,300.00 |
| Jun 30, 2024 | 897,712.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 96,340.00 |
| Jun 30, 2023 | 281,587.00 |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Sep 30, 2022 | 79,400.00 |
| Jun 30, 2022 | 360,400.00 |
| Mar 31, 2022 | 2.06 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.02 Mn |